Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.61 |
| ▸ | ANPEP | P15144 | 1/20 | 0.57 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.57 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | ECE1 | P42892 | 8/20 | 0.57 |
| ▸ | MME | P08473 | 1/20 | 0.55 |
| ▸ | LTA4H | P09960 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7312793 | 0.90 | ANPEP (0.59) | ACEANPEPERAP2ERAP1KMT2A | |
| SCHEMBL7312777 | 0.90 | ANPEP (0.59) | ACEANPEPERAP2ERAP1KMT2A | |
| SCHEMBL7321552 | 0.88 | ACE (0.67) | ACEANPEPERAP2ERAP1ECE1 | |
| SCHEMBL17813732 | 0.85 | PYGB (0.69) | ACEANPEPERAP2ERAP1ECE1 | |
| SCHEMBL7327655 | 0.85 | PYGB (0.69) | ACEANPEPERAP2ERAP1ECE1 | |
| SCHEMBL7321746 | 0.84 | LTA4H (0.63) | ACEANPEPERAP2ERAP1KMT2A | |
| SCHEMBL30051856 | 0.83 | ACE (0.61) | ACEKMT2AL3MBTL1ECE1MME | |
| SCHEMBL30051317 | 0.83 | ACE (0.66) | ACEKMT2AL3MBTL1ECE1 | |
| SCHEMBL15692337 | 0.83 | ACE (0.66) | ACEKMT2AL3MBTL1ECE1 | |
| SCHEMBL8742457 | 0.83 | NMBR (0.64) | ACEKMT2AL3MBTL1ECE1MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250360206-A1 | CANCER ANTIGENS AND METHODS | THE FRANCIS CRICK INSTITUTE LTD (GB) | 2025-11-27 | — | — | US | disclosed |
| US-12263216-B2 | Cancer antigens and methods | THE FRANCIS CRICK INSTITUTE LIMITED (GB) | 2025-04-01 | — | — | US | disclosed |
| CN-221502412-U | Prefabricated cross laminated timber and cast-in-situ reinforced concrete mixed floor | 南京航空航天大学 | 2024-08-09 | — | — | CN | disclosed |
| CN-108797885-B | Adjustable and controllable prestressed CLT (compact form) string plate | 东北林业大学 | 2024-08-02 | — | — | CN | disclosed |
| CN-117661768-A | Fire-resistant orthogonal glued wood floor board | 上海应用技术大学 | 2024-03-08 | — | — | CN | disclosed |
| US-20230302109-A1 | ANTIGEN POOL | ENARA BIO LIMITED (GB) | 2023-09-28 | — | — | US | disclosed |
| US-20230167163-A1 | FUSION PROTEINS OF CTL ANTIGENS FOR TREATING MELANOMA | ENARA BIO LIMITED (GB) | 2023-06-01 | — | — | US | disclosed |
| US-20220218807-A1 | NOVEL CANCER ANTIGENS AND METHODS | THE FRANCIS CRICK INSTITUTE LIMITED (GB) | 2022-07-14 | — | — | US | disclosed |
| US-20220220175-A1 | NOVEL CANCER ANTIGENS AND METHODS | ENARA BIO LIMITED (GB) | 2022-07-14 | — | — | US | disclosed |
| US-20220211760-A1 | NOVEL CANCER ANTIGENS AND METHODS | THE FRANCIS CRICK INSTITUTE LIMITED (GB) | 2022-07-07 | — | — | US | disclosed |
| CN-215802553-U | Assembled wood-concrete combined floor slab | 同济大学 | 2022-02-11 | — | — | CN | disclosed |